Cytomegalovirus acquisition in infancy and the risk of tuberculosis disease in childhood: a longitudinal birth cohort study in Cape Town, South Africa

Summary: Background: The risk of tuberculosis disease after recent exposure is greatest before age 5 years; however, the mechanisms explaining this increased risk are not well elucidated. Acquisition of viral infections, such as cytomegalovirus, in early life might modulate the immune system. We ai...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Leonardo Martinez, PhD, Mark P Nicol, ProfPhD, Catherine J Wedderburn, MRCPCH, Attie Stadler, MPH, Maresa Botha, MBChB, Lesley Workman, MPH, David M le Roux, MBChB, Heather J Zar, ProfPhD
Formato: article
Lenguaje:EN
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://doaj.org/article/04a79264ec3f445b88fe8dd87c37461e
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:04a79264ec3f445b88fe8dd87c37461e
record_format dspace
institution DOAJ
collection DOAJ
language EN
topic Public aspects of medicine
RA1-1270
spellingShingle Public aspects of medicine
RA1-1270
Leonardo Martinez, PhD
Mark P Nicol, ProfPhD
Catherine J Wedderburn, MRCPCH
Attie Stadler, MPH
Maresa Botha, MBChB
Lesley Workman, MPH
David M le Roux, MBChB
Heather J Zar, ProfPhD
Cytomegalovirus acquisition in infancy and the risk of tuberculosis disease in childhood: a longitudinal birth cohort study in Cape Town, South Africa
description Summary: Background: The risk of tuberculosis disease after recent exposure is greatest before age 5 years; however, the mechanisms explaining this increased risk are not well elucidated. Acquisition of viral infections, such as cytomegalovirus, in early life might modulate the immune system. We aimed to evaluate the acquisition of cytomegalovirus infection in infancy and the development of tuberculosis disease in children. Methods: In this prospective, birth cohort study we enrolled pregnant women who were between 20 and 28 weeks of gestation attending antenatal care in Paarl, a periurban setting outside of Cape Town, South Africa. Participants were recruited from two clinics (TC Newman and Mbekweni). Infants were given Bacillus Calmette–Guérin vaccination at birth as per national policy. Nasopharyngeal swabs for cytomegalovirus detection using qPCR were done for infants at birth, age 3 and 6 weeks, and age 3, 6, 12, and 24 months. Children were prospectively followed up for tuberculosis disease until age 9 years using tuberculin skin testing, radiographic examinations, GeneXpert, and sputum testing. Tuberculin skin tests were done at the 6-month visit and then at age 12, 24, 36, 48, and 60 months, and at the time of lower respiratory tract infection. We compared tuberculosis disease incidence after age 1 year or after age 6 months in children with and without cytomegalovirus infection using Cox regression and hazard ratios (HRs) with 95% CIs. Findings: Between March 5, 2012, and March 31, 2015, 1225 pregnant women were recruited and enrolled in the birth cohort. 88 (7%) women were excluded because of loss to antenatal follow-up or pregnancy losses. Of 1143 livebirths, 68 (6%) mother–infant pairs were excluded. In total, 963 children were serially tested for cytomegalovirus (7186 cytomegalovirus measurements taken; median six tests per child, IQR 2–11). The prevalence of congenital cytomegalovirus at age younger than 3 weeks was 2% (18 of 816). Cytomegalovirus positivity increased continuously with age from 3% (27 of 825) by age 6 weeks to 21% (183 of 882) by 3 months, 35% (315 of 909) by 6 months, and 42% (390 of 933) by 12 months. Mother–infant pairs were followed up for a median of 6·9 years (IQR 6·0–7·8). The risk of tuberculosis disease in children after age 1 year was higher in those with cytomegalovirus infection by age 6 weeks (adjusted HR 4·1, 95% CI 1·2–13·8; p=0·022), 3 months (2·8, 1·4–5·8; p=0·0040), 6 months (3·6, 1·7–7·3; p<0·0001), 12 months (3·2, 1·6–6·4; p=0·0010), and 24 months (4·2, 2·0–8·8; p<0·0001). The risk of microbiologically confirmed tuberculosis disease was also higher among children acquiring cytomegalovirus infection before age 3 months (adjusted HR 3·2, 95% CI 1·0–10·6; p=0·048), 6 months (3·9, 1·2–13·0; p=0·027), 12 months (4·4, 1·2–16·3; p=0·027), and 24 months (6·1, 1·3–27·9; p=0·020). In children older than 1 year, the risk of tuberculosis disease was consistently greater in those with high cytomegalovirus loads than in those with low cytomegalovirus loads that were acquired before age 3 months (adjusted HR 2·0 vs 3·7; ptrend=0·0020; both groups compared with cytomegalovirus negative reference) and before age 12 months (2·7 vs 3·7; ptrend=0·0009). Interpretation: Infants that acquire cytomegalovirus in the first year of life are at high risk of subsequently developing tuberculosis disease. Efforts to prevent tuberculosis in early childhood in high-burden countries might need to deter or delay acquisition of cytomegalovirus perinatally or in the first months of life. Funding: Bill &amp; Melinda Gates Foundation, MRC South Africa, National Research Foundation South Africa, and Wellcome Trust.
format article
author Leonardo Martinez, PhD
Mark P Nicol, ProfPhD
Catherine J Wedderburn, MRCPCH
Attie Stadler, MPH
Maresa Botha, MBChB
Lesley Workman, MPH
David M le Roux, MBChB
Heather J Zar, ProfPhD
author_facet Leonardo Martinez, PhD
Mark P Nicol, ProfPhD
Catherine J Wedderburn, MRCPCH
Attie Stadler, MPH
Maresa Botha, MBChB
Lesley Workman, MPH
David M le Roux, MBChB
Heather J Zar, ProfPhD
author_sort Leonardo Martinez, PhD
title Cytomegalovirus acquisition in infancy and the risk of tuberculosis disease in childhood: a longitudinal birth cohort study in Cape Town, South Africa
title_short Cytomegalovirus acquisition in infancy and the risk of tuberculosis disease in childhood: a longitudinal birth cohort study in Cape Town, South Africa
title_full Cytomegalovirus acquisition in infancy and the risk of tuberculosis disease in childhood: a longitudinal birth cohort study in Cape Town, South Africa
title_fullStr Cytomegalovirus acquisition in infancy and the risk of tuberculosis disease in childhood: a longitudinal birth cohort study in Cape Town, South Africa
title_full_unstemmed Cytomegalovirus acquisition in infancy and the risk of tuberculosis disease in childhood: a longitudinal birth cohort study in Cape Town, South Africa
title_sort cytomegalovirus acquisition in infancy and the risk of tuberculosis disease in childhood: a longitudinal birth cohort study in cape town, south africa
publisher Elsevier
publishDate 2021
url https://doaj.org/article/04a79264ec3f445b88fe8dd87c37461e
work_keys_str_mv AT leonardomartinezphd cytomegalovirusacquisitionininfancyandtheriskoftuberculosisdiseaseinchildhoodalongitudinalbirthcohortstudyincapetownsouthafrica
AT markpnicolprofphd cytomegalovirusacquisitionininfancyandtheriskoftuberculosisdiseaseinchildhoodalongitudinalbirthcohortstudyincapetownsouthafrica
AT catherinejwedderburnmrcpch cytomegalovirusacquisitionininfancyandtheriskoftuberculosisdiseaseinchildhoodalongitudinalbirthcohortstudyincapetownsouthafrica
AT attiestadlermph cytomegalovirusacquisitionininfancyandtheriskoftuberculosisdiseaseinchildhoodalongitudinalbirthcohortstudyincapetownsouthafrica
AT maresabothambchb cytomegalovirusacquisitionininfancyandtheriskoftuberculosisdiseaseinchildhoodalongitudinalbirthcohortstudyincapetownsouthafrica
AT lesleyworkmanmph cytomegalovirusacquisitionininfancyandtheriskoftuberculosisdiseaseinchildhoodalongitudinalbirthcohortstudyincapetownsouthafrica
AT davidmlerouxmbchb cytomegalovirusacquisitionininfancyandtheriskoftuberculosisdiseaseinchildhoodalongitudinalbirthcohortstudyincapetownsouthafrica
AT heatherjzarprofphd cytomegalovirusacquisitionininfancyandtheriskoftuberculosisdiseaseinchildhoodalongitudinalbirthcohortstudyincapetownsouthafrica
_version_ 1718425017262276608
spelling oai:doaj.org-article:04a79264ec3f445b88fe8dd87c37461e2021-11-18T04:48:35ZCytomegalovirus acquisition in infancy and the risk of tuberculosis disease in childhood: a longitudinal birth cohort study in Cape Town, South Africa2214-109X10.1016/S2214-109X(21)00407-1https://doaj.org/article/04a79264ec3f445b88fe8dd87c37461e2021-12-01T00:00:00Zhttp://www.sciencedirect.com/science/article/pii/S2214109X21004071https://doaj.org/toc/2214-109XSummary: Background: The risk of tuberculosis disease after recent exposure is greatest before age 5 years; however, the mechanisms explaining this increased risk are not well elucidated. Acquisition of viral infections, such as cytomegalovirus, in early life might modulate the immune system. We aimed to evaluate the acquisition of cytomegalovirus infection in infancy and the development of tuberculosis disease in children. Methods: In this prospective, birth cohort study we enrolled pregnant women who were between 20 and 28 weeks of gestation attending antenatal care in Paarl, a periurban setting outside of Cape Town, South Africa. Participants were recruited from two clinics (TC Newman and Mbekweni). Infants were given Bacillus Calmette–Guérin vaccination at birth as per national policy. Nasopharyngeal swabs for cytomegalovirus detection using qPCR were done for infants at birth, age 3 and 6 weeks, and age 3, 6, 12, and 24 months. Children were prospectively followed up for tuberculosis disease until age 9 years using tuberculin skin testing, radiographic examinations, GeneXpert, and sputum testing. Tuberculin skin tests were done at the 6-month visit and then at age 12, 24, 36, 48, and 60 months, and at the time of lower respiratory tract infection. We compared tuberculosis disease incidence after age 1 year or after age 6 months in children with and without cytomegalovirus infection using Cox regression and hazard ratios (HRs) with 95% CIs. Findings: Between March 5, 2012, and March 31, 2015, 1225 pregnant women were recruited and enrolled in the birth cohort. 88 (7%) women were excluded because of loss to antenatal follow-up or pregnancy losses. Of 1143 livebirths, 68 (6%) mother–infant pairs were excluded. In total, 963 children were serially tested for cytomegalovirus (7186 cytomegalovirus measurements taken; median six tests per child, IQR 2–11). The prevalence of congenital cytomegalovirus at age younger than 3 weeks was 2% (18 of 816). Cytomegalovirus positivity increased continuously with age from 3% (27 of 825) by age 6 weeks to 21% (183 of 882) by 3 months, 35% (315 of 909) by 6 months, and 42% (390 of 933) by 12 months. Mother–infant pairs were followed up for a median of 6·9 years (IQR 6·0–7·8). The risk of tuberculosis disease in children after age 1 year was higher in those with cytomegalovirus infection by age 6 weeks (adjusted HR 4·1, 95% CI 1·2–13·8; p=0·022), 3 months (2·8, 1·4–5·8; p=0·0040), 6 months (3·6, 1·7–7·3; p<0·0001), 12 months (3·2, 1·6–6·4; p=0·0010), and 24 months (4·2, 2·0–8·8; p<0·0001). The risk of microbiologically confirmed tuberculosis disease was also higher among children acquiring cytomegalovirus infection before age 3 months (adjusted HR 3·2, 95% CI 1·0–10·6; p=0·048), 6 months (3·9, 1·2–13·0; p=0·027), 12 months (4·4, 1·2–16·3; p=0·027), and 24 months (6·1, 1·3–27·9; p=0·020). In children older than 1 year, the risk of tuberculosis disease was consistently greater in those with high cytomegalovirus loads than in those with low cytomegalovirus loads that were acquired before age 3 months (adjusted HR 2·0 vs 3·7; ptrend=0·0020; both groups compared with cytomegalovirus negative reference) and before age 12 months (2·7 vs 3·7; ptrend=0·0009). Interpretation: Infants that acquire cytomegalovirus in the first year of life are at high risk of subsequently developing tuberculosis disease. Efforts to prevent tuberculosis in early childhood in high-burden countries might need to deter or delay acquisition of cytomegalovirus perinatally or in the first months of life. Funding: Bill &amp; Melinda Gates Foundation, MRC South Africa, National Research Foundation South Africa, and Wellcome Trust.Leonardo Martinez, PhDMark P Nicol, ProfPhDCatherine J Wedderburn, MRCPCHAttie Stadler, MPHMaresa Botha, MBChBLesley Workman, MPHDavid M le Roux, MBChBHeather J Zar, ProfPhDElsevierarticlePublic aspects of medicineRA1-1270ENThe Lancet Global Health, Vol 9, Iss 12, Pp e1740-e1749 (2021)